seed
Stage
1
Investors
About
Napiferyn Biotech develops novel oncology therapies based on synthetic peptides, targeting rare cancers.
Explore Napiferyn Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.